GERD (gastroesophageal reflux disease) remains extremely common, affecting an estimated 40% of Americans on at least a weekly basis, despite widespread use of acid-suppressing therapies such as antacids, H2 blockers, and proton-pump inhibitors (PPIs). I have written previously (1) about ...